SDAI
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Background Certolizumab pegol (CZP) is approved for treatment of rheumatoid arthritis. Objectives To explore the predictor of…
Background Golimumab (GLM) is a human anti-tumor necrosis factor (TNF) alpha monoclonal antibody and shown to be effective in the…
Objective. To assess significance of Simplified Disease Activity Index (SDAI) in early arthritis. Material and methods. 76 pts…